These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21965433)

  • 41. Quantitation of HTLV-I proviral load by a real-time PCR assay using SYBR Green: comparison of two methods for DNA isolation.
    Altamirano NA; Rocco C; Aulicino P; Sen L; Mangano A
    J Virol Methods; 2010 Dec; 170(1-2):160-4. PubMed ID: 20816699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low DNA HTLV-2 proviral load among women in São Paulo City.
    Montanheiro P; Olah I; Fukumori LM; Smid J; Oliveira AC; Kanzaki LI; Fonseca LA; Duarte AJ; Casseb J
    Virus Res; 2008 Jul; 135(1):22-5. PubMed ID: 18343520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.
    Nobre V; Guedes AC; Martins ML; Barbosa-Stancioli EF; Serufo JC; Proietti FA; Ribas JG; Ferreira CE; Lambertucci JR;
    Clin Infect Dis; 2006 Nov; 43(10):1257-63. PubMed ID: 17051489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking.
    Sonoda J; Koriyama C; Yamamoto S; Kozako T; Li HC; Lema C; Yashiki S; Fujiyoshi T; Yoshinaga M; Nagata Y; Akiba S; Takezaki T; Yamada K; Sonoda S
    Cancer Sci; 2004 Jul; 95(7):596-601. PubMed ID: 15245597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a real-time PCR assay for a novel HTLV-1 tax sequence detection and proviral load quantitation.
    Castro GM; Balangero MC; Maturano E; Mangeaud A; Gallego SV
    J Virol Methods; 2013 May; 189(2):383-7. PubMed ID: 23499262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
    Dehée A; Césaire R; Désiré N; Lézin A; Bourdonné O; Béra O; Plumelle Y; Smadja D; Nicolas JC
    J Virol Methods; 2002 Apr; 102(1-2):37-51. PubMed ID: 11879691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).
    Mortreux F; Kazanji M; Gabet AS; de Thoisy B; Wattel E
    J Virol; 2001 Jan; 75(2):1083-9. PubMed ID: 11134325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial.
    Nakamura T; Matsuo T; Fukuda T; Yamato S; Yamaguchi K; Kinoshita I; Matsuzaki T; Nishiura Y; Nagasato K; Narita-Masuda T; Nakamura H; Satoh K; Sasaki H; Sakai H; Kawakami A
    BMC Med; 2013 Aug; 11():182. PubMed ID: 23945290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a quantitative real-time PCR assay for HTLV-1 proviral load in peripheral blood mononuclear cells.
    Rosadas C; Cabral-Castro MJ; Vicente AC; Peralta JM; Puccioni-Sohler M
    J Virol Methods; 2013 Nov; 193(2):536-41. PubMed ID: 23911967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human T cell leukemia virus type I-infected patients with Hashimoto's thyroiditis and Graves' disease.
    Matsuda T; Tomita M; Uchihara JN; Okudaira T; Ohshiro K; Tomoyose T; Ikema T; Masuda M; Saito M; Osame M; Takasu N; Ohta T; Mori N
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5704-10. PubMed ID: 16076945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
    Machuca A; Soriano V
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):189-93. PubMed ID: 10935697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections.
    Tosswill JH; Taylor GP; Clewley JP; Weber JN
    J Virol Methods; 1998 Nov; 75(1):21-6. PubMed ID: 9820571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP.
    Enose-Akahata Y; Billioux BJ; Azodi S; Dwyer J; Vellucci A; Ngouth N; Nozuma S; Massoud R; Cortese I; Ohayon J; Jacobson S
    Ann Clin Transl Neurol; 2021 Oct; 8(10):1970-1985. PubMed ID: 34562313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing.
    Matsumoto C; Sagara Y; Sobata R; Inoue Y; Morita M; Uchida S; Kiyokawa H; Satake M; Tadokoro K
    J Med Virol; 2017 Aug; 89(8):1469-1476. PubMed ID: 28252206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.
    Desdouits M; Cassar O; Maisonobe T; Desrames A; Aouba A; Hermine O; Mikol J; Polivka M; Penisson-Besnier I; Marcorelles P; Zagnoli F; Papo T; Lacour A; Amoura Z; Haroche J; Cherin P; Teixeira A; Benveniste O; Herson S; Morin AS; Mortreux F; Wattel E; Huerre M; Cumont MC; Martin-Latil S; Butler-Browne G; Gout O; Taylor G; Gessain A; Ozden S; Ceccaldi PE
    J Clin Virol; 2013 May; 57(1):70-6. PubMed ID: 23375238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proviral load determination of HTLV-1 and HTLV-2 in patients' peripheral blood mononuclear cells by real-time PCR.
    Casoli C; Pilotti E; Bertazzoni U
    Methods Mol Biol; 2014; 1087():315-23. PubMed ID: 24158833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relevance of HTLV-1 proviral load in asymptomatic and symptomatic patients living in endemic and non-endemic areas of Argentina.
    Pineda MV; Bouzas MB; Remesar M; Fridman A; Remondegui C; Mammana L; Altamirano N; Paradiso P; Costantini P; Tadey L; Aulicino P; Mangano A
    PLoS One; 2019; 14(11):e0225596. PubMed ID: 31756234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy.
    Torres-Cornejo A; Benmarzouk-Hidalgo OJ; Gutiérrez-Valencia A; Pérez-Romero P; Martín-Peña R; Ruiz-Valderas R; Viciana P; Lopez-Cortes LF
    AIDS; 2014 Jan; 28(2):201-8. PubMed ID: 24361681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of antiretroviral therapy on HTLV infection.
    Machuca A; Rodés B; Soriano V
    Virus Res; 2001 Oct; 78(1-2):93-100. PubMed ID: 11520583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.